A Cancer Drug Shows Promise, at a Price That Many Can't Pay. Ntech: About Us: Corporate Chronology. Genentech was founded in 1976 by venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer. In the early 1970s, Boyer and geneticist Stanley Cohen pioneered a new scientific field called recombinant DNA technology.
After hearing about Boyer and Cohen's breakthrough, Swanson placed a call to Boyer and requested a meeting. Genentech - Wiki. As of August 2013, Genentech employed more than 12,300 people.[6] The Swiss global health-care company F.
Hoffmann-La Roche AG now completely owns Genentech after completing its purchase on March 26, 2009 for approximately $46.8 billion.[7][8] Research[edit] Genntech: Home.